|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Share-based compensation expense | |||||
| Gain on debt extinguishment | |||||
| Foreign currency transaction loss | |||||
| Other non-cash expenses | |||||
| Impairment of right-of-use assets | |||||
| Changes in assets and liabilities: | |||||
| Accounts receivable | |||||
| Prepaid expenses and other current assets | |||||
| Right-of-use assets | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Deferred revenue | |||||
| Lease liabilities | |||||
| Net cash used in operating activities | |||||
| Investing activities | |||||
| Acquisition of property and equipment | |||||
| Net cash used in investing activities | |||||
| Financing activities | |||||
| Proceeds from debt | |||||
| Proceeds from exercise of stock options | |||||
| Proceeds from issuance of common stock under equity plans | |||||
| Proceeds from issuance of common stock, net of issuance costs | |||||
| Payments on debt obligations | |||||
| Net cash provided by (used in) financing activities | |||||
| Net decrease in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of year | |||||
| Cash, cash equivalents and restricted cash, end of year | |||||
| Supplemental disclosure of cash flow information | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Non-cash investing activities | |||||
| Right-of-use assets acquired through operating leases | |||||
| Non-cash asset disposal | |||||
| Purchase of property and equipment in accounts payable and accrued expenses | |||||
Loading...